Hepatitis C News and Research

Latest Hepatitis C News and Research

More insurers want you to see a doctor virtually

Insurers like WellPoint and Aetna are offering patients the option of e-visits with doctors as a way to cut costs, but some see problems with that, reports Bloomberg. Other media outlets explore the controversy over Sovaldi, an expensive new drug for hepatitis C.

17 Jul 2014

First Edition: July 16, 2014

Today's headlines include reports about the Congressional Budget Office's latest estimate on federal health care spending.

16 Jul 2014

States grapple with mental illness issues; Oregon moves closer to limiting Medicaid patients' access to new hepatitis C drugs

The numbers, posted daily on the Cook County sheriff's website, would be alarming at an urgent care clinic, let alone a jail: On a Wednesday, 36 percent of all new arrivals report having a mental illness. On a Friday, it's 54 percent. But inside the razor wire framing the 96-acre compound, the faces and voices of the newly arrested confirm its accidental role as Chicago's treatment center of last resort for people with serious mental illnesses (Geller, 7/14).

16 Jul 2014

Johnson & Johnson sales increase 9.1% to $19.5 billion in second quarter 2014

Johnson & Johnson today announced sales of $19.5 billion for the second quarter of 2014, an increase of 9.1% as compared to the second quarter of 2013. Operational results increased 9.4% and the negative impact of currency was 0.3%.

15 Jul 2014

Senate Finance Committee probing prices for hepatitis C drug

Sens. Ron Wyden, D-Ore., and Charles Grassley, R-Iowa, send letter to the drug's maker requesting information about how it set the price, which runs about $84,000 for a standard three-month regimen.

15 Jul 2014

First Edition: July 14, 2014

Today's headlines include coverage of Medicare, the health law and veterans' care policy issues as well as reports from the campaign trail.

14 Jul 2014

CRAG urges researchers to balance goal of shortening treatment for MDR-TB with patient safety

In a viewpoint published this week in The Lancet, the Community Research Advisors Group argue that research into bedaquiline – a new drug, fast tracked for multidrug-resistant tuberculosis (MDR-TB) – should proceed cautiously in people with drug-sensitive tuberculosis.

14 Jul 2014

Failure to provide adequate HIV services threatens global progress on HIV response, warns WHO

Failure to provide adequate HIV services for key groups - men who have sex with men, people in prison, people who inject drugs, sex workers and transgender people - threatens global progress on the HIV response, warns WHO.

11 Jul 2014

Research roundup: 20M gain insurance, coverage's effect on surgery choices; opioid use by service members

This report aims to help readers understand recently announced enrollment numbers, as well as other numbers that have received less attention, and assess their importance for the future of the ACA and our health care system. .

4 Jul 2014

New meta-analysis highlights significant gaps in hepatitis C care

A new meta-analysis published online in PLOS ONE by infectious disease and epidemiology specialists from the Perelman School of Medicine at the University of Pennsylvania highlights significant gaps in hepatitis C care that will prove useful as the U.S. health care system continues to see an influx of patients with the disease because of improved screening efforts and new, promising drugs.

3 Jul 2014

Ralphs Pharmacies continue to offer Tdap vaccinations for whooping cough in Southern California

As the number of pertussis cases, also known as whooping cough, reaches epidemic proportions in California, Ralphs Pharmacies continue to offer Tdap (tetanus, diphtheria, pertussis) vaccinations at its 85 in-store pharmacies throughout Southern California.

2 Jul 2014

Isis Pharmaceuticals gets $1 million from GSK to discover and develop drugs for HBV

Isis Pharmaceuticals, Inc. announced today that it has earned a $1 million payment from GlaxoSmithKline related to the advancement of its program to develop antisense drugs to treat hepatitis B virus (HBV).

2 Jul 2014

Biotest Pharmaceuticals opens new plasma collection center in Valdosta, Georgia

Biotest Pharmaceuticals Corporation, a leading developer of immunology biotherapeutic products, is pleased to announce the addition of its newest plasma collection center located at 311 North Patterson Road, in Valdosta, Georgia.

2 Jul 2014

Inaccurate doctor lists hurt access for low-income Californians

Meanwhile, confusion over limited providers also has led to unforeseen bills for enrollees in private plans in California, reports The Los Angeles Times. Other stories look at the growing number of insurers who want to participate in the online marketplaces and how 19 states have passed laws restricting the workers who help consumers sign up, despite a new federal rule eliminating many such restrictions.

1 Jul 2014

Janssen seeks expanded approval of VELCADE from EU for Mantle Cell Lymphoma

Janssen-Cilag International NV today announced its submission of a type II variation to the European Medicines Agency to expand the label for VELCADE (bortezomib) to include its use, in combination with rituximab, cyclophosphamide, doxorubicin and prednisone, for the treatment of adult patients with previously untreated Mantle Cell Lymphoma (MCL).

28 Jun 2014

EMA CHMP adopts positive opinion for Bristol-Myers Squibb’s Daklinza for HCV treatment

Bristol-Myers Squibb Company today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending that Daklinza (daclatasvir), an investigational, potent pan-genotypic NS5A complex inhibitor (in vitro), be granted approval for use in combination with other medicinal products for the treatment of chronic hepatitis C virus (HCV) infection in adults.

27 Jun 2014

Hepatitis C News and Research

Latest Hepatitis C News and Research

More insurers want you to see a doctor virtually

First Edition: July 16, 2014

States grapple with mental illness issues; Oregon moves closer to limiting Medicaid patients' access to new hepatitis C drugs

Johnson & Johnson sales increase 9.1% to $19.5 billion in second quarter 2014

Senate Finance Committee probing prices for hepatitis C drug

First Edition: July 14, 2014

CRAG urges researchers to balance goal of shortening treatment for MDR-TB with patient safety

Failure to provide adequate HIV services threatens global progress on HIV response, warns WHO

Research roundup: 20M gain insurance, coverage's effect on surgery choices; opioid use by service members

New meta-analysis highlights significant gaps in hepatitis C care

Ralphs Pharmacies continue to offer Tdap vaccinations for whooping cough in Southern California

Isis Pharmaceuticals gets $1 million from GSK to discover and develop drugs for HBV

Biotest Pharmaceuticals opens new plasma collection center in Valdosta, Georgia

Inaccurate doctor lists hurt access for low-income Californians

Janssen seeks expanded approval of VELCADE from EU for Mantle Cell Lymphoma

EMA CHMP adopts positive opinion for Bristol-Myers Squibb’s Daklinza for HCV treatment

How will hepatitis C drug affect health care spending?

Alcoholic liver disease: an interview with Dr Vinood Patel, University of Westminster

First Edition: June 24, 2014

Antiviral therapy can reduce risk of liver cancer in patients with chronic hepatitis B infection

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Hepatitis C News and Research

Latest Hepatitis C News and Research

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in